Literature DB >> 27085072

Why are well-educated Muscovites more likely to survive? Understanding the biological pathways.

Megan A Todd1, Vladimir M Shkolnikov2, Noreen Goldman3.   

Abstract

There are large socioeconomic disparities in adult mortality in Russia, although the biological mechanisms are not well understood. With data from the study of Stress, Aging, and Health in Russia (SAHR), we use Gompertz hazard models to assess the relationship between educational attainment and mortality among older adults in Moscow and to evaluate biomarkers associated with inflammation, neuroendocrine function, heart rate variability, and clinical cardiovascular and metabolic risk as potential mediators of that relationship. We do this by assessing the extent to which the addition of biomarker variables into hazard models of mortality attenuates the association between educational attainment and mortality. We find that an additional year of education is associated with about 5% lower risk of age-specific all-cause and cardiovascular mortality. Inflammation biomarkers are best able to account for this relationship, explaining 25% of the education-all-cause mortality association, and 35% of the education-cardiovascular mortality association. Clinical markers perform next best, accounting for 13% and 23% of the relationship between education and all-cause and cardiovascular mortality, respectively. Although heart rate biomarkers are strongly associated with subsequent mortality, they explain very little of the education-mortality link. Neuroendocrine biomarkers fail to account for any portion of the link. These findings suggest that inflammation may be important for understanding mortality disparities by socioeconomic status.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Aging; Biomarkers; Education; Inflammation; Mortality; Russia; Socioeconomic status

Mesh:

Substances:

Year:  2016        PMID: 27085072      PMCID: PMC5282593          DOI: 10.1016/j.socscimed.2016.02.041

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  75 in total

Review 1.  Insights from the study of heart rate variability.

Authors:  P K Stein; R E Kleiger
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

2.  Occupational determinants of heart rate variability.

Authors:  L G van Amelsvoort; E G Schouten; A C Maan; C A Swenne; F J Kok
Journal:  Int Arch Occup Environ Health       Date:  2000-05       Impact factor: 3.015

Review 3.  Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.

Authors:  K Kuulasmaa; H Tunstall-Pedoe; A Dobson; S Fortmann; S Sans; H Tolonen; A Evans; M Ferrario; J Tuomilehto
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

Review 4.  C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

Authors:  W K Lagrand; C A Visser; W T Hermens; H W Niessen; F W Verheugt; G J Wolbink; C E Hack
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

5.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

6.  Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities.

Authors:  J M Dekker; R S Crow; A R Folsom; P J Hannan; D Liao; C A Swenne; E G Schouten
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

7.  Reproducibility of heart rate measured in the clinic and with 24-hour intermittent recorders.

Authors:  P Palatini; M Winnicki; M Santonastaso; G De Venuto; G Zanata; O Bertolo; G Frigo; A C Pessina
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

8.  Heart rate and mortality in a Japanese general population: an 18-year follow-up study.

Authors:  Y Fujiura; H Adachi; M Tsuruta; D R Jacobs; Y Hirai; T Imaizumi
Journal:  J Clin Epidemiol       Date:  2001-05       Impact factor: 6.437

9.  Heart rate and mortality.

Authors:  A Reunanen; J Karjalainen; P Ristola; M Heliövaara; P Knekt; A Aromaa
Journal:  J Intern Med       Date:  2000-02       Impact factor: 8.989

10.  High urinary catecholamine excretion predicts mortality and functional decline in high-functioning, community-dwelling older persons: MacArthur Studies of Successful Aging.

Authors:  D B Reuben; S L Talvi; J W Rowe; T E Seeman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-10       Impact factor: 6.053

View more
  4 in total

1.  What are the keys to a longer, happier life? Answers from five decades of health psychology research.

Authors:  Blair T Johnson; Rebecca L Acabchuk
Journal:  Soc Sci Med       Date:  2017-11-04       Impact factor: 4.634

2.  Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study.

Authors:  Maria A Shkolnikova; Dmitri A Jdanov; Rukizhat A Ildarova; Natalia V Shcherbakova; Ekaterina B Polyakova; Evgeny N Mikhaylov; Svetlana A Shalnova; Vladimir M Shkolnikov
Journal:  J Geriatr Cardiol       Date:  2020-02       Impact factor: 3.327

3.  Socioeconomic inequalities in physiological risk biomarkers and the role of lifestyles among Russians aged 35-69 years.

Authors:  Sergi Trias-Llimós; Sarah Cook; Anne Elise Eggen; Alexander V Kudryavtsev; Sofia Malyutina; Vladimir M Shkolnikov; David A Leon
Journal:  Int J Equity Health       Date:  2022-04-15

4.  Self-rated health status and illiteracy as death predictors in a Brazilian cohort.

Authors:  Sayuri Inuzuka; Paulo Cesar Veiga Jardim; Shafika Abrahams-Gessel; Ludimila Garcia Souza; Ana Carolina Rezende; Naiana Borges Perillo; Samanta Garcia Souza; Ymara Cássia Luciana Araújo; Rogério Orlow Oliveira; Weimar Sebba Barroso; Andréa Cristina Sousa; Ana Luiza Lima Sousa; Thiago Veiga Jardim
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.